Annual report pursuant to Section 13 and 15(d)

Condensed Financial Statements of Parent Company - Cash Flow Statement (Details)

v3.23.3
Condensed Financial Statements of Parent Company - Cash Flow Statement (Details) - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:      
Net income $ 49,001 $ 21,376 $ 20,177
Adjustments to reconcile net income to net cash (used in) provided by operating activities:      
Depreciation, depletion, accretion and amortization 79,100 65,730 49,806
Gain on sale of equipment (7,048) (3,673) (2,043)
Loss (gain) on derivative instruments 342 (382) (3,209)
Equity-based compensation expense 10,759 8,000 3,549
Deferred income tax benefit 11,165 5,966 3,745
Other non-cash adjustments (263) 40 (46)
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets 3,650 (4,912) (1,759)
Other assets (129) (955) (2,928)
Accrued expenses and other current liabilities 2,340 (11,559) 3,848
Net cash (used in) provided by operating activities 157,157 16,498 48,500
Cash flows from investing activities:      
Purchases of property, plant and equipment (97,810) (68,851) (56,332)
Proceeds from sale of property, plant and equipment 17,698 7,525 3,654
Net cash used in investing activities (143,372) (197,326) (263,412)
Cash flows from financing activities:      
Principal payments on long-term debt (103,125) (8,125) (95,350)
Net cash (used in) provided by financing activities (264) 159,136 123,847
Net change in cash, cash equivalents and restricted cash 13,521 (21,692) (91,065)
Cash, cash equivalents and restricted cash:      
Beginning of year 35,559 57,251 148,316
End of year 49,080 35,559 57,251
Construction Partners Inc | Parent Company      
Cash flows from operating activities:      
Net income 49,001 21,376 20,177
Adjustments to reconcile net income to net cash (used in) provided by operating activities:      
Depreciation, depletion, accretion and amortization 757 757 475
Gain on sale of equipment 0 (6) 0
Loss (gain) on derivative instruments 0 (1,668) (894)
Equity-based compensation expense 10,759 8,000 3,549
Equity in net income of subsidiaries (50,899) (24,690) (25,505)
Deferred income tax benefit 0 (248) (451)
Other non-cash adjustments (417) (73) 9
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets 1,584 (1,932) (135)
Other assets (256) (593) (2,008)
Accrued expenses and other current liabilities 646 507 1,001
Other liabilities 0 (748) (97)
Net cash (used in) provided by operating activities 11,175 682 (3,879)
Cash flows from investing activities:      
Purchases of property, plant and equipment (737) (243) (2,641)
Proceeds from sale of property, plant and equipment 0 6 0
Investment in subsidiary (29,317) (10,986) 0
Net cash used in investing activities (30,054) (11,223) (2,641)
Cash flows from financing activities:      
Change in amounts due to (from) subsidiaries, net 32,126 (65,622) (6,296)
Purchase of treasury stock (139) (39) 0
Principal payments on long-term debt (1,828) (420) 0
Proceeds from issuance of long-term debt, net of debt issuance costs and discount 0 54,527 0
Net cash (used in) provided by financing activities 30,159 (11,554) (6,296)
Net change in cash, cash equivalents and restricted cash 11,280 (22,095) (12,816)
Cash, cash equivalents and restricted cash:      
Beginning of year 43,130 65,225 78,041
End of year $ 54,410 $ 43,130 $ 65,225